Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $122.4300 (0.92%) ($122.4300 - $122.4300) on Tue. Jul. 20, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.62% (three month average) | RSI | 34 | Latest Price | $122.4300(0.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.1% a day on average for past five trading days. | Weekly Trend | LGND declines -5.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(55%) IWC(53%) IWN(50%) | Factors Impacting LGND price | LGND will decline at least -1.31% in a week (0% probabilities). VIXM(-26%) UUP(-17%) VXX(-16%) IGOV(-6%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.31% (StdDev 2.62%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $110.34(-9.88%) | Resistance Level | $127.52 | 5 Day Moving Average | $118.08(3.68%) | 10 Day Moving Average | $122.25(0.15%) | 20 Day Moving Average | $127.52(-3.99%) | To recent high | -19.2% | To recent low | 8.4% | Market Cap | $1.968b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |